US20110023869A1 - Delivery devices - Google Patents

Delivery devices Download PDF

Info

Publication number
US20110023869A1
US20110023869A1 US12/516,401 US51640107A US2011023869A1 US 20110023869 A1 US20110023869 A1 US 20110023869A1 US 51640107 A US51640107 A US 51640107A US 2011023869 A1 US2011023869 A1 US 2011023869A1
Authority
US
United States
Prior art keywords
delivery device
outlet
cavity
substance
mouthpiece
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/516,401
Inventor
Per Gisle Djupesland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optinose AS
Original Assignee
Optinose AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optinose AS filed Critical Optinose AS
Assigned to OPTINOSE AS reassignment OPTINOSE AS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DJUPESLAND, PER GISLE
Publication of US20110023869A1 publication Critical patent/US20110023869A1/en
Assigned to OPTINOSE AS reassignment OPTINOSE AS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NILSSON, ANDREAS, PERICE, CHRISTOPHE, ANDREASSEN, ERIK, DJUPESLAND, PER GISLE, GAARDER, RUNE HARALD
Priority to US15/133,356 priority Critical patent/US20170043108A1/en
Assigned to OPTINOSE AS reassignment OPTINOSE AS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NILSSON, ANDREAS, PERICE, CHRISTOPHE, ANDREASSEN, ERIK, DJUPESLAND, PER GISLE, GAARDER, RUNE HARALD
Assigned to OPTINOSE AS reassignment OPTINOSE AS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DJUPESLAND, PER GISLE, NILSSON, ANDREAS, PERICE, CHRISTOPHE, ANDREASSEN, ERIK, GAARDER, RUNE HARALD
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • A61M15/0098Activated by exhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0005Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/002Details of inhalators; Constructional features thereof with air flow regulating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids

Definitions

  • the present invention relates to a delivery device for and method of delivering a metered volume of substance, in particular a delivery device for delivering a metered volume of a liquid substance to a nasal cavity of a subject.
  • Very many delivery devices exist for the delivery of liquid substances, which typically comprise a manually-actuated pump for the delivery of a liquid substance as an aerosol spray.
  • the present invention provides a delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising: a mouthpiece through which the user in use exhales; an outlet from which substance is delivered; and a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
  • the cavity is an elongate cavity.
  • the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.
  • the ball sealingly engages with an inner peripheral wall of the cavity.
  • the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and preferably less than about 3 kPa.
  • the outlet nozzle provides for an aerosol spray.
  • the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from exit of the outlet nozzle.
  • outlet nozzle provides for a jet.
  • the delivery device further comprises: a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.
  • the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.
  • the delivery device further comprises: a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.
  • the delivery device further comprises: a baffle member which is disposed in the fluid communication path.
  • the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit.
  • the baffle member includes a plurality of entraining air flow channels.
  • the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.
  • the housing includes an outlet chamber downstream of the baffle member.
  • the outlet chamber surrounds the dispensing unit.
  • the outlet includes a flow restrictor for providing a flow restriction thereat.
  • the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece.
  • the flow restrictor has a frusto-conical section.
  • the delivery device further comprises: a flow regulator which is disposed at the outlet nozzle of the dispensing unit.
  • the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.
  • the delivery device is configured to deliver a liquid.
  • the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.
  • FIG. 1 illustrates a part-sectional perspective view of a delivery device in accordance with a preferred embodiment of the present invention
  • FIG. 2 illustrates a longitudinal sectional view of the delivery device of FIG. 1 , where in the rest or non-actuated state;
  • FIGS. 3( a ) to ( c ) illustrate three delivery profiles for the delivered substance obtainable by the delivery device of FIG. 1 ;
  • FIG. 4 illustrates the delivery device of FIG. 1 , where in the actuated state
  • FIG. 5 illustrates a part-sectional perspective view of a delivery device as a modification of the delivery device of FIG. 1 ;
  • FIG. 6 illustrates a longitudinal sectional view of the delivery device of FIG. 5 .
  • the delivery device comprises a first, inlet housing part 3 which defines a mouthpiece 5 at one, inlet end thereof and an inlet chamber 7 which is in fluid communication with the mouthpiece 5 and the other, outlet end of which is open, such that exhalation by a user into the mouthpiece 5 delivers an air flow into the inlet chamber 7 and to the open, outlet end thereof.
  • the mouthpiece 5 comprises a tubular section which is gripped in the lips of the user.
  • the inlet chamber 7 flares outwardly from the mouthpiece 5 , here having a frusto-conical section.
  • the delivery device further comprises a baffle member 11 which sealingly engages the open, outlet end of the inlet chamber 7 , such as to direct the air flow as delivered through the inlet chamber 7 .
  • the baffle member 11 includes a first, driving air pressure channel 21 at which a driving pressure is created, which acts to drive a liquid dispensing unit 35 , as will be described in more detail hereinbelow, and at least one, in this embodiment a plurality of second, entraining air flow channels 23 through which an entraining air flow F is delivered.
  • the first, driving air pressure channel 21 is located on the longitudinal axis of the inlet chamber 7 .
  • the driving air pressure channel 21 has a circular section, here having a diameter of at or less than about 6 mm.
  • the entraining air flow channels 23 are located such as to be in fluid communication with the periphery of the open, outlet end of the inlet chamber 7 .
  • the baffle member 11 includes four entraining air flow channels 23 which are disposed uniformly on an annulus about the longitudinal axis of the inlet housing part 3 , and each have a circular section, here having a diameter of at or less than about 4 mm.
  • the baffle member 11 comprises first and second baffle elements 25 , 27 , here plates which are disposed in juxtaposed relation.
  • the delivery device further comprises a pressure regulator 29 which includes an aperture 31 which is fluidly connected to the driving air pressure channel 21 in the baffle member 11 , in this embodiment at the downstream end thereof, such as to provide for the generation of a predetermined pressure thereat.
  • the aperture 31 has a circular section, here having a diameter of at or less than about 4 mm.
  • the delivery device further comprises a liquid dispensing unit 35 which is fluidly connected to the pressure regulator 29 such as to be actuated by the driving air pressure P as generated on exhalation by the user through the mouthpiece 5 .
  • the liquid dispensing unit 35 comprises a body member 37 , in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L, a dispensing member 41 which is movably disposed in the cavity 39 , such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39 , and an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.
  • a body member 37 in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L
  • a dispensing member 41 which is movably disposed in the cavity 39 , such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39
  • an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.
  • the cavity 39 has a volume of about 1 ml. In another embodiment the cavity 39 could have a volume of or less than about 200 ⁇ l.
  • the dispensing member 41 is initially disposed at one end of the cavity 39 adjacent the flow regulator 29 and is moved to the other end of the cavity 39 under the action of the driving air pressure, with the liquid L as contained in the cavity 39 being progressively dispensed as the dispensing member 41 is moved along the cavity 39 .
  • the dispensing member 41 and the cavity 39 of the liquid dispensing unit 35 are configured to provide for movement with a driving air pressure P at or less than about 5 kPa and preferably at or less than about 3 kPa.
  • the dispensing member 41 is a ball which sealingly engages the peripheral wall of the cavity 39 .
  • the outlet nozzle 43 includes an outlet orifice 45 which is shaped and dimensioned, in this embodiment having a circular section, to provide the dispensed liquid with a predetermined profile.
  • the outlet orifice 45 is configured to dispense the liquid L such that the flow of liquid L remains substantially rectilinear for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from the exit of the outlet orifice 45 and thereafter provide a dispersed aerosol spray, as illustrated in FIG. 3( a ).
  • outlet orifice 45 can be configured to provide a liquid jet, either with some dispersion in the form of a shower of droplets, as illustrated in FIG. 3( b ), or with no dispersion, as illustrated in FIG. 3( c ).
  • the outlet orifice 45 has a diameter of at or less than about 3 mm, preferably at or less than about 2 mm, and more preferably at or less than about 1 mm.
  • the outlet nozzle 43 includes a frangible membrane which normally encloses the outlet orifice 45 thereof such as to contain the liquid L and is ruptured on the application of the driving air pressure P to the liquid L.
  • the delivery device further comprises a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57 , in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35 , which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.
  • a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57 , in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35 , which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.
  • the delivery device further comprises a flow regulator 61 which encloses the annular outlet chamber 57 at the outlet end of the body member 37 of the liquid dispensing unit 35 .
  • the flow regulator 61 includes a plurality of flow apertures 63 , in this embodiment sixteen apertures, which are located on an annulus surrounding the body member 37 of the liquid dispensing unit 35 , such as to provide for the delivery of a substantially annular entraining air flow F which entrains the liquid L as dispensed from the liquid-containing cavity 39 of the liquid dispensing unit 35 .
  • the flow regulator 61 is configured to provide for a flow rate of at least about 20 l/min, more preferably at least about 30 l/min, still more preferably at least about 40 l/min and yet more preferably at least about 50 l/min.
  • the flow apertures 63 have a circular section, here of a diameter of at or less than about 1 mm.
  • a user first inserts the nosepiece 53 into one of his/her nostrils and then grips the mouthpiece 5 in his/her lips.
  • the delivery device has been illustrated in an elongate configuration where the nosepiece 53 and the mouthpiece 5 are located on a common axis.
  • the nosepiece 53 and the mouthpiece 5 would be inclined relative to one another, such as to facilitate fitting of the nosepiece 53 and the mouthpiece 5 in respective ones of a nostril and the lips.
  • This exhalation acts to generate a driving air pressure P at the driving air pressure channel 21 in the baffle member 11 and an entraining air flow F through the entraining air flow channels 23 in the baffle member 11 , which entraining air flow F continues through the outlet chamber 57 and the flow apertures 63 in the entraining air flow regulator 61 , which define a substantially annular entraining air flow F which surrounds the outlet end of the liquid dispensing unit 35 .
  • the driving air pressure P as created at the driving air pressure channel 21 simultaneously acts on the dispensing member 41 , which is located in the cavity 39 of the liquid dispensing unit 35 , such as to move the same along the cavity 39 and dispense the liquid L as contained therein from the outlet end thereof into the entraining air flow F, which surrounds the same, thereby providing for delivery of the liquid L, in this embodiment into the nasal cavity of the user.
  • the delivery device in providing for the delivery of the liquid L in an entraining air flow F, advantageously provides for delivery into and through the nasal airway in the manner as described in the applicant's earlier WO-A-2000/051672, the content of which is herein incorporated by reference.
  • the delivery device can further comprise a flow restrictor 71 at the outlet end of the outlet housing part 51 which defines the nosepiece 53 .
  • the flow restrictor 71 tapers inwardly, here with a frusto-conical section 73 , towards the outlet end of the outlet housing part 51 .
  • the flow restrictor 71 defines an outlet which has a circular section.
  • the outlet of the flow restrictor 71 has a diameter of at or less than about 8 mm, preferably at or less than about 6 mm and more preferably at or less than about 4 mm, and the angle of the tapering section 73 of the flow restrictor 71 has an angle of at or less than about 60 degrees, preferably at or less than about 55 degrees and more preferably at or less than about 52 degrees relative to a plane perpendicular to the longitudinal axis of the outlet housing part 51 .

Abstract

A delivery device for delivering a metered amount of substance (L) in response to exhalation by a user, the delivery device comprising: a mouthpiece (5) through which the user in use exhales; an outlet (45) from which substance Is delivered; and a dispensing unit (35) which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member (37) which includes a cavity (39) for containing a metered amount of substance, an outlet nozzle (43) which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing (41) member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.

Description

  • The present invention relates to a delivery device for and method of delivering a metered volume of substance, in particular a delivery device for delivering a metered volume of a liquid substance to a nasal cavity of a subject.
  • Very many delivery devices exist for the delivery of liquid substances, which typically comprise a manually-actuated pump for the delivery of a liquid substance as an aerosol spray.
  • Whilst these delivery devices have found extensive application, the present inventors have recognized the need for a delivery device which utilizes the exhalation breath of a user as the driving force to deliver a metered dose of a liquid substance.
  • In one aspect the present invention provides a delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising: a mouthpiece through which the user in use exhales; an outlet from which substance is delivered; and a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
  • In one embodiment the cavity is an elongate cavity.
  • In one embodiment the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.
  • In one embodiment the ball sealingly engages with an inner peripheral wall of the cavity.
  • In one embodiment the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and preferably less than about 3 kPa.
  • In one embodiment the outlet nozzle provides for an aerosol spray.
  • In one embodiment the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from exit of the outlet nozzle.
  • In another embodiment the outlet nozzle provides for a jet.
  • In one embodiment the delivery device further comprises: a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.
  • In one embodiment the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.
  • In one embodiment the delivery device further comprises: a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.
  • In one embodiment the delivery device further comprises: a baffle member which is disposed in the fluid communication path.
  • In one embodiment the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit.
  • In one embodiment the baffle member includes a plurality of entraining air flow channels.
  • In one embodiment the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.
  • In one embodiment the housing includes an outlet chamber downstream of the baffle member.
  • In one embodiment the outlet chamber surrounds the dispensing unit.
  • In one embodiment the outlet includes a flow restrictor for providing a flow restriction thereat.
  • In one embodiment the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece.
  • In one embodiment the flow restrictor has a frusto-conical section.
  • In one embodiment the delivery device further comprises: a flow regulator which is disposed at the outlet nozzle of the dispensing unit.
  • In one embodiment the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.
  • In one embodiment the delivery device is configured to deliver a liquid.
  • In one embodiment the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.
  • A preferred embodiment of the present invention will now be described hereinbelow by way of example only with reference to the accompanying drawings, in which:
  • FIG. 1 illustrates a part-sectional perspective view of a delivery device in accordance with a preferred embodiment of the present invention;
  • FIG. 2 illustrates a longitudinal sectional view of the delivery device of FIG. 1, where in the rest or non-actuated state;
  • FIGS. 3( a) to (c) illustrate three delivery profiles for the delivered substance obtainable by the delivery device of FIG. 1;
  • FIG. 4 illustrates the delivery device of FIG. 1, where in the actuated state;
  • FIG. 5 illustrates a part-sectional perspective view of a delivery device as a modification of the delivery device of FIG. 1; and
  • FIG. 6 illustrates a longitudinal sectional view of the delivery device of FIG. 5.
  • The delivery device comprises a first, inlet housing part 3 which defines a mouthpiece 5 at one, inlet end thereof and an inlet chamber 7 which is in fluid communication with the mouthpiece 5 and the other, outlet end of which is open, such that exhalation by a user into the mouthpiece 5 delivers an air flow into the inlet chamber 7 and to the open, outlet end thereof.
  • In this embodiment the mouthpiece 5 comprises a tubular section which is gripped in the lips of the user.
  • In this embodiment the inlet chamber 7 flares outwardly from the mouthpiece 5, here having a frusto-conical section.
  • The delivery device further comprises a baffle member 11 which sealingly engages the open, outlet end of the inlet chamber 7, such as to direct the air flow as delivered through the inlet chamber 7.
  • The baffle member 11 includes a first, driving air pressure channel 21 at which a driving pressure is created, which acts to drive a liquid dispensing unit 35, as will be described in more detail hereinbelow, and at least one, in this embodiment a plurality of second, entraining air flow channels 23 through which an entraining air flow F is delivered.
  • In this embodiment the first, driving air pressure channel 21 is located on the longitudinal axis of the inlet chamber 7. In this embodiment the driving air pressure channel 21 has a circular section, here having a diameter of at or less than about 6 mm.
  • In this embodiment the entraining air flow channels 23 are located such as to be in fluid communication with the periphery of the open, outlet end of the inlet chamber 7. In this embodiment the baffle member 11 includes four entraining air flow channels 23 which are disposed uniformly on an annulus about the longitudinal axis of the inlet housing part 3, and each have a circular section, here having a diameter of at or less than about 4 mm.
  • In this embodiment the baffle member 11 comprises first and second baffle elements 25, 27, here plates which are disposed in juxtaposed relation.
  • The delivery device further comprises a pressure regulator 29 which includes an aperture 31 which is fluidly connected to the driving air pressure channel 21 in the baffle member 11, in this embodiment at the downstream end thereof, such as to provide for the generation of a predetermined pressure thereat. In this embodiment the aperture 31 has a circular section, here having a diameter of at or less than about 4 mm.
  • The delivery device further comprises a liquid dispensing unit 35 which is fluidly connected to the pressure regulator 29 such as to be actuated by the driving air pressure P as generated on exhalation by the user through the mouthpiece 5.
  • The liquid dispensing unit 35 comprises a body member 37, in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L, a dispensing member 41 which is movably disposed in the cavity 39, such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39, and an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.
  • In this embodiment the cavity 39 has a volume of about 1 ml. In another embodiment the cavity 39 could have a volume of or less than about 200 μl.
  • In this embodiment the dispensing member 41 is initially disposed at one end of the cavity 39 adjacent the flow regulator 29 and is moved to the other end of the cavity 39 under the action of the driving air pressure, with the liquid L as contained in the cavity 39 being progressively dispensed as the dispensing member 41 is moved along the cavity 39.
  • In this embodiment the dispensing member 41 and the cavity 39 of the liquid dispensing unit 35 are configured to provide for movement with a driving air pressure P at or less than about 5 kPa and preferably at or less than about 3 kPa.
  • In this embodiment the dispensing member 41 is a ball which sealingly engages the peripheral wall of the cavity 39.
  • The outlet nozzle 43 includes an outlet orifice 45 which is shaped and dimensioned, in this embodiment having a circular section, to provide the dispensed liquid with a predetermined profile. In this embodiment the outlet orifice 45 is configured to dispense the liquid L such that the flow of liquid L remains substantially rectilinear for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from the exit of the outlet orifice 45 and thereafter provide a dispersed aerosol spray, as illustrated in FIG. 3( a). In an alternative embodiment the outlet orifice 45 can be configured to provide a liquid jet, either with some dispersion in the form of a shower of droplets, as illustrated in FIG. 3( b), or with no dispersion, as illustrated in FIG. 3( c).
  • In preferred embodiments the outlet orifice 45 has a diameter of at or less than about 3 mm, preferably at or less than about 2 mm, and more preferably at or less than about 1 mm.
  • In this embodiment the outlet nozzle 43 includes a frangible membrane which normally encloses the outlet orifice 45 thereof such as to contain the liquid L and is ruptured on the application of the driving air pressure P to the liquid L.
  • The delivery device further comprises a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57, in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35, which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.
  • The delivery device further comprises a flow regulator 61 which encloses the annular outlet chamber 57 at the outlet end of the body member 37 of the liquid dispensing unit 35.
  • In this embodiment the flow regulator 61 includes a plurality of flow apertures 63, in this embodiment sixteen apertures, which are located on an annulus surrounding the body member 37 of the liquid dispensing unit 35, such as to provide for the delivery of a substantially annular entraining air flow F which entrains the liquid L as dispensed from the liquid-containing cavity 39 of the liquid dispensing unit 35.
  • In this embodiment the flow regulator 61 is configured to provide for a flow rate of at least about 20 l/min, more preferably at least about 30 l/min, still more preferably at least about 40 l/min and yet more preferably at least about 50 l/min.
  • In this embodiment the flow apertures 63 have a circular section, here of a diameter of at or less than about 1 mm.
  • Operation of the above-described delivery device will now be described hereinbelow with reference to FIG. 4 of the accompanying drawings.
  • A user first inserts the nosepiece 53 into one of his/her nostrils and then grips the mouthpiece 5 in his/her lips. It should be understood that, for the sake of ease of illustration, the delivery device has been illustrated in an elongate configuration where the nosepiece 53 and the mouthpiece 5 are located on a common axis. In practice, the nosepiece 53 and the mouthpiece 5 would be inclined relative to one another, such as to facilitate fitting of the nosepiece 53 and the mouthpiece 5 in respective ones of a nostril and the lips.
  • The user then exhales through the mouthpiece 5, which is in fluid communication with the inlet chamber 7.
  • This exhalation acts to generate a driving air pressure P at the driving air pressure channel 21 in the baffle member 11 and an entraining air flow F through the entraining air flow channels 23 in the baffle member 11, which entraining air flow F continues through the outlet chamber 57 and the flow apertures 63 in the entraining air flow regulator 61, which define a substantially annular entraining air flow F which surrounds the outlet end of the liquid dispensing unit 35.
  • The driving air pressure P as created at the driving air pressure channel 21 simultaneously acts on the dispensing member 41, which is located in the cavity 39 of the liquid dispensing unit 35, such as to move the same along the cavity 39 and dispense the liquid L as contained therein from the outlet end thereof into the entraining air flow F, which surrounds the same, thereby providing for delivery of the liquid L, in this embodiment into the nasal cavity of the user.
  • In this embodiment the delivery device, in providing for the delivery of the liquid L in an entraining air flow F, advantageously provides for delivery into and through the nasal airway in the manner as described in the applicant's earlier WO-A-2000/051672, the content of which is herein incorporated by reference.
  • Finally, it will be understood that the present invention has been described in its preferred embodiment and can be modified in many different ways without departing from the scope of the invention as defined by the appended claims.
  • In one modification, as illustrated in FIGS. 5 and 6, the delivery device can further comprise a flow restrictor 71 at the outlet end of the outlet housing part 51 which defines the nosepiece 53. In this embodiment the flow restrictor 71 tapers inwardly, here with a frusto-conical section 73, towards the outlet end of the outlet housing part 51. In this embodiment the flow restrictor 71 defines an outlet which has a circular section. In preferred embodiments the outlet of the flow restrictor 71 has a diameter of at or less than about 8 mm, preferably at or less than about 6 mm and more preferably at or less than about 4 mm, and the angle of the tapering section 73 of the flow restrictor 71 has an angle of at or less than about 60 degrees, preferably at or less than about 55 degrees and more preferably at or less than about 52 degrees relative to a plane perpendicular to the longitudinal axis of the outlet housing part 51. With this configuration, a faster delivery of the liquid L can be achieved as compared to the above-described embodiment.

Claims (25)

1. A delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising:
a mouthpiece through which the user in use exhales;
an outlet from which substance is delivered; and
a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
2. The delivery device of claim 1, wherein the cavity is an elongate cavity.
3. The delivery device of claim 2, wherein the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.
4. The delivery device of claim 3, wherein the ball sealingly engages with an inner peripheral wall of the cavity.
5. The delivery device of claim 1, wherein the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and optionally less than about 3 kPa.
6. The delivery device of claim 1, wherein the outlet nozzle provides for an aerosol spray.
7. The delivery device of claim 6, wherein the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, optionally at least about 20 mm, optionally at least about 25 mm and optionally at least about 30 mm from exit of the outlet nozzle.
8. The delivery device of claim 1, wherein the outlet nozzle provides for a jet.
9. The delivery device of claim 1, further comprising:
a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.
10. The delivery device of claim 1, wherein the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.
11. The delivery device of claim 10, further comprising:
a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.
12. The delivery device of claim 11, further comprising:
a baffle member which is disposed in the fluid communication path.
13. The delivery device of claim 12, wherein the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit, optionally the baffle member includes a plurality of entraining air flow channels.
14. (canceled)
15. The delivery device of claim 12, wherein the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.
16. The delivery device of claim 12, wherein the housing includes an outlet chamber downstream of the baffle member, optionally the outlet chamber surrounds the dispensing unit.
17. (canceled)
18. The delivery device of claim 10, wherein the outlet includes a flow restrictor for providing a flow restriction thereat.
19. The delivery device of claim 18, wherein the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece, optionally the flow restrictor has a frusto-conical section.
20. (canceled)
21. The delivery device of claim 10, further comprising:
a flow regulator which is disposed at the outlet nozzle of the dispensing unit, optionally the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.
22. (canceled)
23. The delivery device of claim 1, where configured to deliver a liquid.
24. The delivery device of claim 1, wherein the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.
25. (canceled)
US12/516,401 2006-11-28 2007-11-28 Delivery devices Abandoned US20110023869A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/133,356 US20170043108A1 (en) 2006-11-28 2016-04-20 Delivery devices

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0623731.7A GB0623731D0 (en) 2006-11-28 2006-11-28 Delivery device
GB0623731.7 2006-11-28
PCT/IB2007/004353 WO2008081326A2 (en) 2006-11-28 2007-11-28 Delivery devices

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004353 A-371-Of-International WO2008081326A2 (en) 2006-11-28 2007-11-28 Delivery devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/171,554 Continuation US20150007811A1 (en) 2006-11-28 2014-02-03 Delivery devices

Publications (1)

Publication Number Publication Date
US20110023869A1 true US20110023869A1 (en) 2011-02-03

Family

ID=37671442

Family Applications (4)

Application Number Title Priority Date Filing Date
US12/516,401 Abandoned US20110023869A1 (en) 2006-11-28 2007-11-28 Delivery devices
US14/171,554 Abandoned US20150007811A1 (en) 2006-11-28 2014-02-03 Delivery devices
US15/133,356 Abandoned US20170043108A1 (en) 2006-11-28 2016-04-20 Delivery devices
US15/936,251 Active 2028-07-07 US10639438B2 (en) 2006-11-28 2018-03-26 Delivery devices

Family Applications After (3)

Application Number Title Priority Date Filing Date
US14/171,554 Abandoned US20150007811A1 (en) 2006-11-28 2014-02-03 Delivery devices
US15/133,356 Abandoned US20170043108A1 (en) 2006-11-28 2016-04-20 Delivery devices
US15/936,251 Active 2028-07-07 US10639438B2 (en) 2006-11-28 2018-03-26 Delivery devices

Country Status (3)

Country Link
US (4) US20110023869A1 (en)
GB (2) GB0623731D0 (en)
WO (1) WO2008081326A2 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070039614A1 (en) * 2003-05-20 2007-02-22 Djupesland Per G Delivery device and method
US20070125371A1 (en) * 2003-08-28 2007-06-07 Optinose As Delivery devices
US20080161771A1 (en) * 2001-02-26 2008-07-03 Optinose As Nasal delevery devices
US20080289629A1 (en) * 2004-09-15 2008-11-27 Optinose As Nasal Delivery Devices
US20090101146A1 (en) * 2002-07-02 2009-04-23 Per Gisle Djupesland Nasal devices
US20090293873A1 (en) * 2005-02-23 2009-12-03 Optinose As Powder delivery devices
US20100091965A1 (en) * 2007-12-13 2010-04-15 Huawei Technologies Co., Ltd. Service subscription method, system and server
US20110053827A1 (en) * 2006-06-08 2011-03-03 Optinose As Intranasal administration
US9205208B2 (en) 2001-06-12 2015-12-08 Optinose As Nasal devices
US20160015915A1 (en) * 2013-03-06 2016-01-21 Hsd Holding Smart Device S.R.L. Element for Inhaling Medicinal Substances
USD759805S1 (en) 2013-05-23 2016-06-21 Optinose As Nosepiece unit
US9452272B2 (en) 2003-08-14 2016-09-27 Optinose As Delivery devices
US9649456B2 (en) 2007-04-05 2017-05-16 Optinose As Nasal administration
US20170304568A1 (en) * 2014-09-02 2017-10-26 Université François-Rabelais De Tours Device for nasal spraying of fluid product
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
US20180126101A1 (en) * 2011-05-09 2018-05-10 Impel Neuropharma Inc. Nozzles for nasal drug delivery
US10076615B2 (en) 2007-04-05 2018-09-18 Optinose As Nasal delivery
US10076614B2 (en) 2012-02-24 2018-09-18 Optinose As Nasal delivery devices
US10076602B2 (en) 2013-11-05 2018-09-18 Benedict GERBER Nasal douche with valve that can be actuated by respiratory air
US10124132B2 (en) 2006-03-06 2018-11-13 Optinose As Nasal delivery
US10179216B2 (en) 2012-02-24 2019-01-15 Optinose As Nasal delivery devices
US10252010B2 (en) 2007-10-03 2019-04-09 Optinose As Nasal delivery devices
US10300229B2 (en) 2012-02-24 2019-05-28 Optinose As Nasal delivery devices
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
US10525218B2 (en) 2006-11-28 2020-01-07 Optinose As Nasal delivery devices
US10639438B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10639437B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10765829B2 (en) 2006-07-25 2020-09-08 Optinose As Delivery of gases to the nasal airway
US10864334B2 (en) 2006-03-23 2020-12-15 Optinose As Nasal delivery
US10940277B2 (en) 2014-11-19 2021-03-09 Optinose As Intranasal administration
US11291626B2 (en) 2010-09-14 2022-04-05 Optinose As Nasal delivery of oxytocin
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272315B (en) * 2013-04-28 2019-02-22 河南科技大学第一附属医院 A kind of inhalation device of the upper respiratory tract
US11925749B2 (en) * 2021-03-18 2024-03-12 Funai Electric Co., Ltd. Venting of pharmaceutical drug delivery device for air flow and humidity control

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820306A (en) * 1981-06-22 1989-04-11 Sterling Drug Inc. Method for augmentation of the alveolar ridge
WO2003084591A1 (en) * 2002-04-04 2003-10-16 Optinose As Nasal devices
US6715485B1 (en) * 1999-03-03 2004-04-06 Optinose As Nasal delivery device
US20040112379A1 (en) * 2001-02-26 2004-06-17 Djupesland Per Gisle Nasal devices
US20050028812A1 (en) * 2000-11-15 2005-02-10 Per Gisle Djupesland Nasal delivery device
US20050072430A1 (en) * 2001-06-12 2005-04-07 Per Gisle Djupesland Nasal devices
US20050235992A1 (en) * 2002-03-28 2005-10-27 Djupesland Per G Nasal devices
US20060096589A1 (en) * 2002-04-25 2006-05-11 Djupesland Per G Nasal devices
US20060169278A1 (en) * 2002-07-09 2006-08-03 Djupesland Per G Delivery devices
US20070039614A1 (en) * 2003-05-20 2007-02-22 Djupesland Per G Delivery device and method
US20070125371A1 (en) * 2003-08-28 2007-06-07 Optinose As Delivery devices
US20070186927A1 (en) * 2003-08-14 2007-08-16 Djupesland Per G Delivery devices
US7377901B2 (en) * 2000-06-21 2008-05-27 Optinose As Apparatus for collection of airway gases
US20080289629A1 (en) * 2004-09-15 2008-11-27 Optinose As Nasal Delivery Devices
US7481218B2 (en) * 2002-07-02 2009-01-27 Optinose As Nasal devices
US20090293873A1 (en) * 2005-02-23 2009-12-03 Optinose As Powder delivery devices
US20090304802A1 (en) * 2006-03-03 2009-12-10 Optinose As Nasal delivery
US20090314293A1 (en) * 2006-03-06 2009-12-24 Optinose As Nasal delivery
US20090320832A1 (en) * 2006-03-23 2009-12-31 Optinose As Nasal delivery
US20100035805A1 (en) * 2006-04-25 2010-02-11 Optinose As Non-aqueous liquid formulation for nasal or buccal administration
US20100057047A1 (en) * 2006-02-14 2010-03-04 Optinose As Delivery device and method
US20100051022A1 (en) * 2006-02-14 2010-03-04 Optinose As Delivery device and method

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US605436A (en) 1898-06-07 Inhaler
US642748A (en) 1899-02-23 1900-02-06 Arthur Manners Inhaler.
US658436A (en) 1900-05-28 1900-09-25 Hans Hennerich Groth Insufflator.
US746749A (en) 1903-03-18 1903-12-15 George E Seidel Nasal medicator.
US794641A (en) 1905-03-06 1905-07-11 Alfred H Ramey Inhaler.
US902832A (en) 1907-09-20 1908-11-03 Edward F Philbrook Inhaler.
NZ298384A (en) 1995-01-23 1998-07-28 Direct Haler As Inhaler - single dose of particulate substance arranged in air flow passage
US5797392C1 (en) 1996-01-22 2001-01-09 Direct Haler As Inhaler
WO1998053869A1 (en) 1997-05-27 1998-12-03 Direct-Haler A/S Inhaler for powdered medicaments
GB0300008D0 (en) 2003-01-02 2003-02-05 Optinose As Delivery devices
USD530815S1 (en) 2004-03-19 2006-10-24 Optinose As Nasal delivery device
CA2642608C (en) 2006-01-19 2018-05-29 Optinose As Nasal administration
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
US20100199984A1 (en) 2007-04-02 2010-08-12 Abbott Laboratories Breath actuated nasal pump
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
EP2242526A4 (en) 2008-02-15 2014-06-18 Timothy Sean Immel Aerosol therapy device with high frequency delivery
US20110318345A1 (en) 2008-09-15 2011-12-29 Optinose As Nasal delivery
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
WO2012123819A1 (en) 2011-03-15 2012-09-20 Optinose As Et Al Nasal delivery
WO2013124492A1 (en) 2012-02-24 2013-08-29 Optinose As Nasal delivery devices
MX352029B (en) 2012-02-24 2017-11-07 Optinose As Nasal delivery devices.
DK2817053T3 (en) 2012-02-24 2018-08-13 Optinose As NATIONAL SUBMISSION DEVICES
KR102345816B1 (en) 2013-03-26 2021-12-30 옵티노즈 에이에스 Nasal administration
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD723156S1 (en) 2013-05-23 2015-02-24 Optinose As Nasal delivery device
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
USD725769S1 (en) 2013-05-23 2015-03-31 Optinose As Nasal delivery device
ES2813442T3 (en) 2014-11-19 2021-03-23 Optinose As Intranasal administration

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820306A (en) * 1981-06-22 1989-04-11 Sterling Drug Inc. Method for augmentation of the alveolar ridge
US20060219240A1 (en) * 1999-03-03 2006-10-05 Djupesland Per G Nasal delivery device
US20060225732A1 (en) * 1999-03-03 2006-10-12 Djupesland Per G Nasal delivery device
US20040182388A1 (en) * 1999-03-03 2004-09-23 Djupesland Per Gisle Nasal delivery method
US20080223363A1 (en) * 1999-03-03 2008-09-18 Optinose As Nasal Delivery Devices
US6715485B1 (en) * 1999-03-03 2004-04-06 Optinose As Nasal delivery device
US20060219241A1 (en) * 1999-03-03 2006-10-05 Djupesland Per G Nasal delivery device
US20060231094A1 (en) * 1999-03-03 2006-10-19 Djupesland Per G Nasal delivery device
US20080221471A1 (en) * 2000-06-21 2008-09-11 Per Djupesland Apparatus for collection of airway gases
US7377901B2 (en) * 2000-06-21 2008-05-27 Optinose As Apparatus for collection of airway gases
US20050028812A1 (en) * 2000-11-15 2005-02-10 Per Gisle Djupesland Nasal delivery device
US7543581B2 (en) * 2001-02-26 2009-06-09 Optinose As Nasal devices
US7347201B2 (en) * 2001-02-26 2008-03-25 Optinose As Nasal delivery devices
US20040112379A1 (en) * 2001-02-26 2004-06-17 Djupesland Per Gisle Nasal devices
US20080161771A1 (en) * 2001-02-26 2008-07-03 Optinose As Nasal delevery devices
US7740014B2 (en) * 2001-02-26 2010-06-22 Optinose As Nasal devices
US20050072430A1 (en) * 2001-06-12 2005-04-07 Per Gisle Djupesland Nasal devices
US20080163874A1 (en) * 2001-09-06 2008-07-10 Optinose As Nasal delivery device
US20050235992A1 (en) * 2002-03-28 2005-10-27 Djupesland Per G Nasal devices
WO2003084591A1 (en) * 2002-04-04 2003-10-16 Optinose As Nasal devices
US20060096589A1 (en) * 2002-04-25 2006-05-11 Djupesland Per G Nasal devices
US7481218B2 (en) * 2002-07-02 2009-01-27 Optinose As Nasal devices
US20090101146A1 (en) * 2002-07-02 2009-04-23 Per Gisle Djupesland Nasal devices
US20060169278A1 (en) * 2002-07-09 2006-08-03 Djupesland Per G Delivery devices
US20070039614A1 (en) * 2003-05-20 2007-02-22 Djupesland Per G Delivery device and method
US20070186927A1 (en) * 2003-08-14 2007-08-16 Djupesland Per G Delivery devices
US20070125371A1 (en) * 2003-08-28 2007-06-07 Optinose As Delivery devices
US20080289629A1 (en) * 2004-09-15 2008-11-27 Optinose As Nasal Delivery Devices
US20090293873A1 (en) * 2005-02-23 2009-12-03 Optinose As Powder delivery devices
US20100057047A1 (en) * 2006-02-14 2010-03-04 Optinose As Delivery device and method
US20100051022A1 (en) * 2006-02-14 2010-03-04 Optinose As Delivery device and method
US20090304802A1 (en) * 2006-03-03 2009-12-10 Optinose As Nasal delivery
US20090314293A1 (en) * 2006-03-06 2009-12-24 Optinose As Nasal delivery
US20090320832A1 (en) * 2006-03-23 2009-12-31 Optinose As Nasal delivery
US20100035805A1 (en) * 2006-04-25 2010-02-11 Optinose As Non-aqueous liquid formulation for nasal or buccal administration

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080223363A1 (en) * 1999-03-03 2008-09-18 Optinose As Nasal Delivery Devices
US8511303B2 (en) 1999-03-03 2013-08-20 Optinose As Nasal delivery devices
US9468727B2 (en) 2000-11-15 2016-10-18 Optinose As Nasal delivery
US20110088691A1 (en) * 2001-02-26 2011-04-21 Per Gisle Djupesland Nasal Devices
US20080161771A1 (en) * 2001-02-26 2008-07-03 Optinose As Nasal delevery devices
US8522778B2 (en) 2001-02-26 2013-09-03 Optinose As Nasal devices
US9205208B2 (en) 2001-06-12 2015-12-08 Optinose As Nasal devices
US20090101146A1 (en) * 2002-07-02 2009-04-23 Per Gisle Djupesland Nasal devices
US9132249B2 (en) 2002-07-02 2015-09-15 Optinose As Nasal devices
US9522243B2 (en) 2002-07-02 2016-12-20 Optinose As Nasal devices
US8047202B2 (en) 2002-07-02 2011-11-01 Optinose As Nasal devices
US10286164B2 (en) 2003-05-20 2019-05-14 Optinose As Delivery device and method
US20070039614A1 (en) * 2003-05-20 2007-02-22 Djupesland Per G Delivery device and method
US9566402B2 (en) 2003-05-20 2017-02-14 Optinose As Delivery Device and Method
US9452272B2 (en) 2003-08-14 2016-09-27 Optinose As Delivery devices
US20070125371A1 (en) * 2003-08-28 2007-06-07 Optinose As Delivery devices
US10737045B2 (en) 2003-08-28 2020-08-11 Optinose As Delivery devices
US8590530B2 (en) 2004-09-15 2013-11-26 Optinose As Nasal delivery devices
US10398859B2 (en) 2004-09-15 2019-09-03 Optinose As Nasal delivery devices
US20080289629A1 (en) * 2004-09-15 2008-11-27 Optinose As Nasal Delivery Devices
US9108015B2 (en) 2004-09-15 2015-08-18 Optinose As Nasal delivery devices
US11571531B2 (en) 2005-02-23 2023-02-07 OptiNose Inc. Powder delivery devices
US9144652B2 (en) * 2005-02-23 2015-09-29 Optinose As Powder delivery devices
US20150101605A1 (en) * 2005-02-23 2015-04-16 Optinose As Powder delivery devices
US8899229B2 (en) 2005-02-23 2014-12-02 Optinose As Powder delivery devices
US20090293873A1 (en) * 2005-02-23 2009-12-03 Optinose As Powder delivery devices
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
US10124132B2 (en) 2006-03-06 2018-11-13 Optinose As Nasal delivery
US10864334B2 (en) 2006-03-23 2020-12-15 Optinose As Nasal delivery
US20110053827A1 (en) * 2006-06-08 2011-03-03 Optinose As Intranasal administration
US10112021B2 (en) 2006-06-08 2018-10-30 Optinose As Intranasal administration
US10765829B2 (en) 2006-07-25 2020-09-08 Optinose As Delivery of gases to the nasal airway
US11690969B2 (en) 2006-07-25 2023-07-04 OptiNose Inc. Delivery of gases to the nasal airway
US10639437B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10639438B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10525218B2 (en) 2006-11-28 2020-01-07 Optinose As Nasal delivery devices
US10722667B2 (en) 2007-04-05 2020-07-28 Optinose As Nasal administration
US10076615B2 (en) 2007-04-05 2018-09-18 Optinose As Nasal delivery
US9649456B2 (en) 2007-04-05 2017-05-16 Optinose As Nasal administration
US11602603B2 (en) 2007-10-03 2023-03-14 Optinose, Inc. Nasal delivery devices
US11083858B2 (en) 2007-10-03 2021-08-10 Optinose As Nasal delivery devices
US10252010B2 (en) 2007-10-03 2019-04-09 Optinose As Nasal delivery devices
US20100091965A1 (en) * 2007-12-13 2010-04-15 Huawei Technologies Co., Ltd. Service subscription method, system and server
US11291626B2 (en) 2010-09-14 2022-04-05 Optinose As Nasal delivery of oxytocin
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
US11890412B2 (en) 2011-05-09 2024-02-06 Impel Pharmaceuticals Inc. Nozzles for nasal drug delivery
US10940278B2 (en) 2011-05-09 2021-03-09 Impel Neuropharma, Inc. Nozzles for nasal drug delivery
US20180126101A1 (en) * 2011-05-09 2018-05-10 Impel Neuropharma Inc. Nozzles for nasal drug delivery
US11007332B2 (en) * 2011-05-09 2021-05-18 Impel Neuropharma, Inc. Nozzles for nasal drug delivery
RU2741249C2 (en) * 2011-05-09 2021-01-22 Импел Ньюрофарма Инк. Tips for nasal drug delivery
US10076614B2 (en) 2012-02-24 2018-09-18 Optinose As Nasal delivery devices
US10179216B2 (en) 2012-02-24 2019-01-15 Optinose As Nasal delivery devices
US11033696B2 (en) 2012-02-24 2021-06-15 Optinose As Nasal delivery devices
US10300229B2 (en) 2012-02-24 2019-05-28 Optinose As Nasal delivery devices
US10220168B2 (en) * 2013-03-06 2019-03-05 Hsd Holding Smart Device S.R.L. Element for inhaling medicinal substances
US20160015915A1 (en) * 2013-03-06 2016-01-21 Hsd Holding Smart Device S.R.L. Element for Inhaling Medicinal Substances
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD809128S1 (en) 2013-05-23 2018-01-30 Optinose As Nosepiece unit
USD759805S1 (en) 2013-05-23 2016-06-21 Optinose As Nosepiece unit
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
US10076602B2 (en) 2013-11-05 2018-09-18 Benedict GERBER Nasal douche with valve that can be actuated by respiratory air
US10814079B2 (en) * 2014-09-02 2020-10-27 Universite De Tours Device for nasal spraying of fluid product
US20170304568A1 (en) * 2014-09-02 2017-10-26 Université François-Rabelais De Tours Device for nasal spraying of fluid product
US11052204B2 (en) 2014-11-19 2021-07-06 Optinose As Intranasal administration
US10940277B2 (en) 2014-11-19 2021-03-09 Optinose As Intranasal administration
US11707586B2 (en) 2014-11-19 2023-07-25 OptiNose Inc. Intranasal administration
US11730904B2 (en) 2014-11-19 2023-08-22 Optinose, Inc. Intranasal administration

Also Published As

Publication number Publication date
US10639438B2 (en) 2020-05-05
GB0723295D0 (en) 2008-01-09
US20190099565A1 (en) 2019-04-04
WO2008081326A2 (en) 2008-07-10
GB2444394B (en) 2011-05-18
GB0623731D0 (en) 2007-01-10
GB2444394A (en) 2008-06-04
WO2008081326A3 (en) 2008-10-23
US20150007811A1 (en) 2015-01-08
US20170043108A1 (en) 2017-02-16

Similar Documents

Publication Publication Date Title
US10639438B2 (en) Delivery devices
US9038630B2 (en) Delivery devices
US20210196904A1 (en) Mixing channel for an inhalation device and inhalation device
AU712312B2 (en) Breathing circuit apparatus for a nebulizer
CN106573117B (en) Liquid medicament cartridge and related dispenser
AU755989B2 (en) Low spray force, low retention atomization system
US5655520A (en) Flexible valve for administering constant flow rates of medicine from a nebulizer
US5297543A (en) Medication inhaler mixer
EP0520571A1 (en) Atomising nozzle
US20120227735A1 (en) Nebulizer for a aerosoltherapy
JP2007535352A (en) Nebulizer for administering medical fluids
JP2005530535A (en) System including nozzle and fixing means thereof
US3320952A (en) Nasal applicators
CN101980738A (en) Circumferential aerosol device
US20220096759A1 (en) Nebulizer and Reservoir
DK142132B (en) Aerosol nebulizer with manually operated atomisers.
JPH09502921A (en) Discharge device for flowable media
US20050023295A1 (en) Dosing device with an application top
GB2476731A (en) Delivery device
GB2461433A (en) Delivery devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: OPTINOSE AS, NORWAY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DJUPESLAND, PER GISLE;REEL/FRAME:023082/0779

Effective date: 20090806

AS Assignment

Owner name: OPTINOSE AS, NORWAY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DJUPESLAND, PER GISLE;ANDREASSEN, ERIK;GAARDER, RUNE HARALD;AND OTHERS;SIGNING DATES FROM 20100525 TO 20100709;REEL/FRAME:031242/0896

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: OPTINOSE AS, NORWAY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DJUPESLAND, PER GISLE;ANDREASSEN, ERIK;GAARDER, RUNE HARALD;AND OTHERS;SIGNING DATES FROM 20100525 TO 20100709;REEL/FRAME:042705/0719

Owner name: OPTINOSE AS, NORWAY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DJUPESLAND, PER GISLE;ANDREASSEN, ERIK;GAARDER, RUNE HARALD;AND OTHERS;SIGNING DATES FROM 20100525 TO 20110831;REEL/FRAME:042705/0885